IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson Innovation - Jjdc, Inc.

Q4 2019 Holdings

Filed 2020-02-14 | 11 holdings | $210.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals, Inc.(ARWR)COM04280A100$206.8M3,260,86998.3%
Aldeyra Therapeutics, Inc.(ALDX)COM01438T106$3.5M594,8341.6%
BiomX Inc.COM09090D103$20.7K2,133,4020.0%
Protagonist Therapeutics, Inc.(PTGX)COM74366E102$17.3K2,449,1830.0%
Provention Bio, Inc.(PRVBUSD)COM74374N102$16.8K1,124,9730.0%
PhaseBio Pharmaceuticals, Inc.COM717224109$9.8K1,607,0440.0%
Castlight Health, Inc.(CSLT1EUR)CL B14862Q100$1.1K811,2950.0%
Senseonics Holdings, Inc(SENS1GBP)COM81727U105$481525,6320.0%
Catalyst Biosciences, Inc.COM NEW14888D208$45666,9510.0%
Genocea Biosciences, Inc.(GNCAQ)COM NEW372427401$298143,9640.0%
Tracon Pharmaceuticals, Inc.COM NEW89237H209$19784,0030.0%